Page last updated: 2024-10-23

azathioprine and Low Bone Density

azathioprine has been researched along with Low Bone Density in 4 studies

Azathioprine: An immunosuppressive agent used in combination with cyclophosphamide and hydroxychloroquine in the treatment of rheumatoid arthritis. According to the Fourth Annual Report on Carcinogens (NTP 85-002, 1985), this substance has been listed as a known carcinogen. (Merck Index, 11th ed)
azathioprine : A thiopurine that is 6-mercaptopurine in which the mercapto hydrogen is replaced by a 1-methyl-4-nitroimidazol-5-yl group. It is a prodrug for mercaptopurine and is used as an immunosuppressant, prescribed for the treatment of inflammatory conditions and after organ transplantation and also for treatment of Crohn's didease and MS.

Research Excerpts

ExcerptRelevanceReference
"At the distal radius, osteopenia was found in all the groups."2.69Bone loss in long-term renal transplantation: histopathology and densitometry analysis. ( Adams, JE; Crowley, V; Cueto-Manzano, AM; France, MW; Freemont, AJ; Gokal, R; Hutchison, AJ; Konel, S; Mawer, B, 1999)
"There is a high prevalence of low bone mineral density (BMD) among patients with inflammatory bowel disease (IBD) although there is a lack of clinical data on the impact of IBD specific medications and recommended vitamin D (VD) and calcium (Ca) supplements on it."1.40Combination therapy with an immunomodulator and anti-TNFα agent improves bone mineral density in IBD patients. ( Cierny, D; Hlavaty, T; Huorka, M; Killinger, Z; Koller, T; Krajcovicova, A; Letkovsky, J; Miznerova, E; Nevidanska, M; Payer, J; Toth, J; Zelinkova, Z, 2014)
"Osteoporosis, osteopenia, and osteonecrosis are common in renal transplant recipients."1.36Bone disease in renal transplantation and pleotropic effects of vitamin D therapy. ( Balal, M; Binokay, F; Demir, E; Erken, U; Kurt, C; Paydas, S; Sertdemir, Y; Sikgenc, MM, 2010)
"Azathioprine treatment alone did not alter ionized calcium, 1,25(OH)2VitD, or PTH levels."1.29Azathioprine alone is bone sparing and does not alter cyclosporin A-induced osteopenia in the rat. ( Armstrong, EC; Bryer, HP; Buchinsky, FJ; Epstein, S; Isserow, JA; Mann, GN; Romero, DF; Rucinski, B, 1995)

Research

Studies (4)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's2 (50.00)18.2507
2000's0 (0.00)29.6817
2010's2 (50.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Krajcovicova, A1
Hlavaty, T1
Killinger, Z1
Miznerova, E1
Toth, J1
Letkovsky, J1
Nevidanska, M1
Cierny, D1
Koller, T1
Zelinkova, Z1
Huorka, M1
Payer, J1
Sikgenc, MM1
Paydas, S1
Balal, M1
Demir, E1
Kurt, C1
Sertdemir, Y1
Binokay, F1
Erken, U1
Bryer, HP1
Isserow, JA1
Armstrong, EC1
Mann, GN1
Rucinski, B1
Buchinsky, FJ1
Romero, DF1
Epstein, S1
Cueto-Manzano, AM1
Konel, S1
Hutchison, AJ1
Crowley, V1
France, MW1
Freemont, AJ1
Adams, JE1
Mawer, B1
Gokal, R1

Trials

1 trial available for azathioprine and Low Bone Density

ArticleYear
Bone loss in long-term renal transplantation: histopathology and densitometry analysis.
    Kidney international, 1999, Volume: 55, Issue:5

    Topics: Absorptiometry, Photon; Adult; Age Factors; Anti-Inflammatory Agents; Azathioprine; Bone Density; Bo

1999

Other Studies

3 other studies available for azathioprine and Low Bone Density

ArticleYear
Combination therapy with an immunomodulator and anti-TNFα agent improves bone mineral density in IBD patients.
    Journal of Crohn's & colitis, 2014, Volume: 8, Issue:12

    Topics: Absorptiometry, Photon; Adalimumab; Adult; Aged; Anti-Inflammatory Agents; Antibodies, Monoclonal; A

2014
Bone disease in renal transplantation and pleotropic effects of vitamin D therapy.
    Transplantation proceedings, 2010, Volume: 42, Issue:7

    Topics: Azathioprine; Bone Density; Bone Diseases; Bone Diseases, Metabolic; Creatinine; Female; Humans; Kid

2010
Azathioprine alone is bone sparing and does not alter cyclosporin A-induced osteopenia in the rat.
    Journal of bone and mineral research : the official journal of the American Society for Bone and Mineral Research, 1995, Volume: 10, Issue:1

    Topics: Animals; Azathioprine; Body Weight; Bone Diseases, Metabolic; Calcitriol; Calcium; Cyclosporine; Dis

1995